None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Age between 18-50yrs -Willing to consent and participate in the study
Exclusion criteria
Exclusion criteria: -Known allergy of milk and milk products -Severely B12 deficient (less than 100 pmol/L) -Anemia (Hemoglobin less than 7 g/ 100 ml) -Pregnant or lactating or planning for pregnancy in the study period -Already taking supplements containing vitamin B12 for 15 or more days -On treatment with drugs known to impair the absorption or utilization of B12 (eg phenytoin, antacids, metformin) -Medical conditions interfering with B12 absorption and utilization; chronic gastro-intestinal disease -Chronic illnesses preventing participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| plasma vitamin B12 concentrationsTimepoint: baseline and 120 days post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| N/ATimepoint: N/A | — |
Countries
India
Contacts
KEM Hospital Research Centre